Scientists

Lin Lin is an immunologist with expertise in T-cell receptor therapies (TCR-Ts) development. She has a particular interest in identifying TCRs that target glioblastoma-specific antigens and seeks to ultimately develop immunotherapeutic strategies to help effectively treat patients with glioblastoma but also other cancers.

Kelly Hotchkiss has expertise in developing pre-clinical immune cell culture, synthetic biology, in vitro and in vivo models as well as evaluations of biological systems from a biomedical engineering perspective.